AGM/EGMApr 30, 2026, 08:38 AM
ACRV 2026 Annual Meeting Set for June 17; Director Elections & Auditor Ratification
AI Summary
Acrivon Therapeutics, Inc. announced its 2026 Annual Meeting of Stockholders will take place virtually on Wednesday, June 17, 2026, at 1:00 PM Eastern Time. Stockholders will vote on the election of two Class I director nominees, Michael Tomsicek and Charles Baum, each for a three-year term. Additionally, the meeting includes a proposal to ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
Key Highlights
- ACRV's 2026 Annual Meeting of Stockholders will be held virtually on June 17, 2026, at 1:00 PM Eastern Time.
- Stockholders will vote to elect Michael Tomsicek, M.B.A. and Charles Baum, M.D., Ph.D. as Class I directors for three-year terms.
- Stockholders will also ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for fiscal year 2026.
- The record date for voting at the Annual Meeting is April 23, 2026.
- Proxy materials were mailed to stockholders on April 30, 2026.
- The Board of Directors unanimously recommends a "FOR" vote for both director nominees and the auditor ratification.
Price Impact
More from ACRV